These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18514320)

  • 1. The canine model with chronic, complete atrio-ventricular block.
    Oros A; Beekman JD; Vos MA
    Pharmacol Ther; 2008 Aug; 119(2):168-78. PubMed ID: 18514320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk.
    Gintant GA
    Pharmacol Ther; 2008 Aug; 119(2):199-209. PubMed ID: 18621077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
    Oosterhoff P; Oros A; Vos MA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():73-8. PubMed ID: 17584687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-septal pacing reduces ventricular electrical remodeling and proarrhythmia in chronic atrioventricular block dogs.
    Winckels SK; Thomsen MB; Oosterhoff P; Oros A; Beekman JD; Attevelt NJ; Kretzers L; Vos MA
    J Am Coll Cardiol; 2007 Aug; 50(9):906-13. PubMed ID: 17719479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
    Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
    Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
    Boulaksil M; Jungschleger JG; Antoons G; Houtman MJ; de Boer TP; Wilders R; Beekman JD; Maessen JG; van der Hulst FF; van der Heyden MA; van Veen TA; van Rijen HV; de Bakker JM; Vos MA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):566-76. PubMed ID: 21622813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
    Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
    Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs.
    Stams TR; Oosterhoff P; Heijdel A; Dunnink A; Beekman JD; van der Nagel R; van Rijen HV; van der Heyden MA; Vos MA
    Circ J; 2016 May; 80(6):1336-45. PubMed ID: 27151565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes liability inter-model comparisons: the experience of the QT PRODACT initiative.
    Hashimoto K
    Pharmacol Ther; 2008 Aug; 119(2):195-8. PubMed ID: 18486227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias.
    Thomsen MB; Matz J; Volders PG; Vos MA
    Pharmacol Ther; 2006 Oct; 112(1):150-70. PubMed ID: 16714061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes.
    Carlsson L
    Pharmacol Ther; 2008 Aug; 119(2):160-7. PubMed ID: 18558435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term Variability of Repolarization Is Superior to Other Repolarization Parameters in the Evaluation of Diverse Antiarrhythmic Interventions in the Chronic Atrioventricular Block Dog.
    Bossu A; Varkevisser R; Beekman HDM; Houtman MJC; van der Heyden MAG; Vos MA
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):398-407. PubMed ID: 28574954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts.
    Sugiyama A
    Br J Pharmacol; 2008 Aug; 154(7):1528-37. PubMed ID: 18552873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tridimensional activation patterns of acquired torsade-de-pointes tachycardias in dogs with chronic AV-block.
    Schreiner KD; Voss F; Senges JC; Becker R; Kraft P; Bauer A; Kelemen K; Kuebler W; Vos MA; Schoels W
    Basic Res Cardiol; 2004 Jul; 99(4):288-98. PubMed ID: 15221347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
    Takahara A; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block.
    Bignolais O; Quang KL; Naud P; El Harchi A; Briec F; Piron J; Bourge A; Leoni AL; Charpentier F; Demolombe S
    J Mol Cell Cardiol; 2011 Nov; 51(5):713-21. PubMed ID: 21787784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the rabbit with a failing heart to test for torsadogenicity.
    Hamlin RL; Kijtawornrat A
    Pharmacol Ther; 2008 Aug; 119(2):179-85. PubMed ID: 18691764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-rate pacing reduces variability of repolarization and prevents repolarization-dependent arrhythmias in dogs with chronic AV block.
    Oosterhoff P; Thomsen MB; Maas JN; Atteveld NJ; Beekman JD; VAN Rijen HV; VAN DER Heyden MA; Vos MA
    J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1384-91. PubMed ID: 20561108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.